Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy

NCT01673204 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01673204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01673204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2012
Completion date
Not reported
Enrollment
276 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy